Blue Owl Capital Holdings »

Cabaletta Bio shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 715k 3.11
2025-06-30 $1.7M 1.1M 1.52

More positions owned by Blue Owl Capital Holdings

Space Exploration Techn Corp Class A Com Stk (SPCX)
Aktis Oncology (AKTS)
Cullinan Oncology (CGEM)
Larimar Therapeutics (LRMR)
Nuveen Churchill Direct Lend Com Shs (NCDL)
Maplight Therapeutics (MPLT)
Capital One Financial (COF)
Owl Rock Capital Corporation (OBDC)
Deep Fission Ord
Dell Technologies CL C (DELL)
Holley (HLLY)
Eyepoint Com New (EYPT)
Sagimet Biosciences Com Ser A (SGMT)
Corvus Pharmaceuticals (CRVS)
Artiva Biotherapeutics (ARTV)

View all positions for Blue Owl Capital Holdings

Top funds holding Cabaletta Bio

Jennison Associates
Bain Capital Life Sciences Investors
BlackRock
Adage Capital Partners GP
Vanguard Capital Management
Cormorant Asset Management
Woodline Partners
Citadel Advisors
Norges Bank Investment Management
Opaleye Management
Geode Capital Management
Susquehanna International
Franklin Resources
Goldman Sachs Group
Millennium Management

View all funds holding Cabaletta Bio